alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.2

                        CERTIFICATION PURSUANT TO
                             18 U.S.C. 1350,
                          AS ADOPTED PURSUANT TO
               SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of PRECISION PETROLEUM CORPORATION
(the "Company") on Form 10-Q for the quarter ended March 31, 2011, as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, James Kirby, Chief Financial Officer of the Company and Chief
Financial Officer of the Company certify, pursuant to 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.



Date:  May 23, 2011


By:  /s/ James Kirby
     ------------------------------------------------
         James Kirby
         Chief Financial Officer, principal financial
         officer and principal accounting officer


<PAGE>
[Federal Register Volume 73, Number 25 (Wednesday, February 6, 2008)]
[Notices]
[Page 6983]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-499]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Division of Microbiology and 
Infectious Diseases: Regulatory Affairs Support.
    Date: February 28-29, 2008.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Rd., NW., Tenleytown Ballroom, Washington, DC 20015.
    Contact Person: Roberta Binder, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892, (301) 496-7966, <a href="/cdn-cgi/l/email-protection#0b796962656f6e794b65626a626f25656263256c647d"><span class="__cf_email__" data-cfemail="7406161d1a101106341a1d151d105a1a1d1c5a131b02">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    January 30, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-499 Filed 2-5-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Pioneer Tax Free Income Fund
                                 60 State Street
                                Boston, MA 02109



                                  July 17, 2008

VIA EDGAR

U.S. Securities and Exchange Commission Division of Investment Management
100 F Street, N.E.
Washington, D.C. 20549

Attention:  Mr. Larry Greene, Esq.

Re:      Delaying Amendment for Pioneer Tax Free Income Fund (the "Registrant")
         Registration Statement on Form N-14 (the "Registration Statement")
         (File No. 333-151757)

Ladies and Gentlemen:

         Pursuant to Rule 473 under the Securities Act of 1933, as amended (the
"Securities Act"), the Registrant is hereby filing a delaying amendment with
respect its Registration Statement relating to the proposed merger of Pioneer
Municipal and Equity Income Trust into the Registrant. The Registration
Statement was filed with the Securities and Exchange Commission (the
"Commission") on June 18, 2008 pursuant to Rule 488 under the Securities Act.

         The Registrant hereby amends the Registration Statement to delay its
effective date until the Registrant shall file a further amendment which
specifically states that the Registration Statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act or until the
Registration Statement shall become effective on such date as the Commission,
acting pursuant to Section 8(a), may determine.

         Pursuant to the requirements of the Securities Act and Rule 478
thereunder, this delaying amendment has been signed on behalf of the Registrant,
in the City of Boston and the Commonwealth of Massachusetts, on the 17th day of
July, 2008.

         If you have any questions or comments, please do not hesitate to
contact Toby Serkin, Esq. ((617) 951-8760) or Jeremy Kantrowitz, Esq.
((617)-951-8458), counsel to the Registrant.


                                                  PIONEER TAX FREE INCOME FUND

                                                  /s/ Christopher J. Kelley

                                                  By: Christopher J. Kelley
                                                  Title:  Assistant Secretary
AGENDA 

Advisory Board on Radiation and Worker Health 

Uranium Refining AWEs Work Group 

November 21, 2011 

Cincinnati Airport Marriott 

2395 Progress Dr., Hebron, KY 41048 

859-586-0166 

Conference Call Number: 1-866-659-0537 

Participant Pass Code: 9933701 

9:00 a.m. (Eastern Time) Welcome and roll-call/introductions 

Work Group Discussion 

Hooker Electrochemical 

 Surrogate data review (SC&A paper) 

 Petitioner issues (October 2 email) 

 WG Recommendation to Board 

Electro Metallurgical 

 DCAS progress report 

United Nuclear 

 Air concentration data (1961-62) (DCAS paper) 

 Exposure potential to transuranics (DCAS paper) 

 Petitioner issues (DCAS paper) 

 Thorium intakes (DCAS paper) 

 Path forward/action items 

Baker-Perkins 

 Summary of SC&A Site Profile Review (SC&A paper) 

 Path forward/action items 

WG Plans 

Adjourn
I,  Andre Benard, the President, Chief Executive Officer and Chief Financial Officer of Calibert Explorations Ltd.. (the Registrant), certify that; (1)I have reviewed this Quarterly Report on Form 10-Q of the Registrant;(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;(4)I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) for the Registrant and have:a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant is made known to me by others within those entities, particularly during the period in which this report is being prepared;b)Evaluated the effectiveness of the Registrants disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; andc)Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and(5)I have disclosed, based on my most recent evaluation of the internal control over financial reporting, to the Registrants auditors and the audit committee of Registrants board of directors (or persons performing the equivalent functions):a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrants ability to record, process, summarize and report financial information; andb)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrants internal control over financial reporting.  April 13, 2009/s/  Andre BenardBy:Andre BenardPresident, Chief Executive Officerand Chief Financial Officer
[Federal Register Volume 73, Number 28 (Monday, February 11, 2008)]
[Notices]
[Page 7750]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-580]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Dental and Craniofacial Research; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Emphasis Panel, Review R03, R21, F30 Applications.
    Date: March 6, 2008.
    Time: 11:30 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Room 674, Bethesda, MD 20892. (Telephone 
Conference Call.)
    Contact Person: Raj K. Krishnaraju, PhD, MS, Scientific Review 
Officer, Scientific Review Branch, National Inst of Dental & 
Craniofacial Research, National Institutes of Health, 45 Center Dr., 
Rm 4AN 32J, Bethesda, MD 20892, 301-594-4864, 
<a href="/cdn-cgi/l/email-protection#2d46465f445e45434c6d4344494e5f03434445034a425b"><span class="__cf_email__" data-cfemail="335858415a405b5d52735d5a5750411d5d5a5b1d545c45">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral 
Diseases and Disorders Research, National Institutes of Health, HHS)

    Dated: February 4, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-580 Filed 2-8-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**Exhibit 32.1**

**Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act**

**of 2002**

In connection with the Annual Report of Cannabis Science, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dr. Robert Melamede, Chief Executive Officer of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  May 4, 2010

*/s/ Dr. Robert Melamede*

Dr. Robert Melamede

President and Chief Executive Officer
CERTIFICATE OF AMENDMENT
                                       OF
                            ARTICLES OF INCORPORATION
                                       OF
                                  ZAPWORLD.COM

The undersigned certify that:

1.        They are the president and the secretary, respectively, of
          Zapworld.com, a California corporation.

2.        Article IV of the Articles of Incorporation of this corporation is
          amended to read as follows:

                  "(a) The corporation is authorized to issue two classes of
                  stock designated `Common Stock' and `Preferred Stock,'
                  respectively. The number of shares of Common Stock the
                  corporation is authorized to issue is twenty million
                  (20,000,000). The number of shares of Preferred Stock the
                  corporation is authorized to issue is ten million
                  (10,000,000).

                  "(b) The Preferred Stock may be divided into such number of
                  series as the board of directors may determine. The board of
                  directors is authorized to determine and alter the rights,
                  preferences, privileges, and restrictions granted to or
                  imposed upon any wholly unissued series of Preferred Stock,
                  and to fix the number of shares and the designation of any
                  series of Preferred Stock. The board of directors may, within
                  the limits stated in any resolution or resolutions of the
                  board of directors originally fixing the number of shares
                  constituting any series, increase or decrease (but not below
                  the number of shares of such series then outstanding) the
                  number of shares of any series subsequent to the issue of
                  shares of that series."

3.        The foregoing amendment of Articles of Incorporation has been duly
          approved by the board of directors.

4.        The foregoing amendment of Articles of Incorporation has been duly
          approved by the required vote of shareholders in accordance with
          Section 902 of the California Corporations Code. The total number of
          outstanding shares of Common Stock of the corporation is 5,226,594.
          There are no outstanding shares of Preferred Stock. The number of
          shares of Common Stock voting in favor of the amendment exceeded the
          vote required. The percentage vote required was more than 50% of the
          outstanding shares.
<PAGE>

We further declare under penalty of perjury under the laws of the State of
California that the matters set forth in this certificate are true and correct
of our own knowledge.

Date: June 26, 2000


                                        ------------------------------------
                                         Gary Starr, President


                                        ------------------------------------
                                         Joni Arellanes, Secretary


                                      -2-
1 

AGENDA

Advisory Board on Radiation and Worker Health – Meeting 130

DoubleTree by Hilton Hotel Oak Ridge - Knoxville

215 S. Illinois Avenue

Oak Ridge, TN 37830

Phone: 865-481-2468; Fax: 865-481-2474

Teleconference Phone: 866-659-0537, Participant Code: 9933701# 

Skype Link: https://webconf.cdc.gov/zab6/yzdq02pl?sl=1 

Wednesday, August 21 2019 

NOTE: All times in Eastern Time 

8:15 a.m. – 9:00 a.m. Annual Ethics Training 

(Members Only)

Ms. Leah Stromberg, HHS 

* * * Public Sessions * * *

9:00 a.m. – 9:15 a.m. Welcome (POTUS designate), Chair

9:15 a.m. – 9:30 a.m. NIOSH Program Update Mr. Grady Calhoun, NIOSH 

9:30 a.m. – 9:45 a.m. DOL Program Update Mr. Frank (Chris) Crawford, 

DOL 

9:45 a.m. –10:00 a.m. DOE Program Update Mr. Greg Lewis, DOE

10:00 a.m. – 10:15 a.m. Break

10:15 a.m. – 11:00 a.m. Board Review of 42 CFR pt. 

81 Amendment to update ICD9 to ICD-10 codes

Mr. David Allen, NIOSH

11:00 a.m. – 12:30 p.m. West Valley Demonstration 

Project SEC Petition # 252 

(West Valley, New York; 

1966-1973)

Ms. Christine Corwin, NIOSH

Petitioners: 

12:30 p.m. – 2:00 p.m. Lunch

2:00 p.m. – 3:00 p.m. Santa Susanna Area IV SEC 

Petition # 235 (Ventura 

County, California; 1991-

1993) 

Mr. Bob Barton, SC&A

Petitioner: 

3:00 p.m. – 3:15 p.m. SEC Petitions Status Update Mr. LaVon Rutherford, 

NIOSH
2 

3: 15 p.m. – 4:15 p.m. Board Work Session (POTUS Designate), Chair

4:15 p.m. - 4:30 p.m. Break

4:30 p.m. – 6:00 p.m. Y-12 SEC Petition #250 (Oak 

Ridge, Tennessee; 1977-1994) 

Dr. Lara Hughes, NIOSH

Petitioners: 

6:00 p.m. – 7:00 p.m.* Public Comment

Adjourn

* Public comment period will conclude at 7:00 p.m. or following the final call for public comment, 

whichever comes first. If you plan to comment, please be prepared to comment at 6:00 p.m.
Exhibit 32.1





CERTIFICATION PURSUANT TO 18 U.S.C.
SECTION 1350,


AS ADOPTED PURSUANT TO SECTION 906
OF


THE SARBANES-OXLEY ACT OF
2002





In connection with the Quarterly Report
on Form 10-Q for the quarterly period ended March 31, 2008 of
Auburn Bancorp, Inc. (the “Company”) as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Allen T. Sterling, President
and Chief Executive Officer of the Company, hereby certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:





(1)
            The Report fully complies with the
      requirements of Section 13(a) or 15(d) of the Securities Exchange Act
      of 1934; and





(2)
            The information contained in the
      Report fairly presents, in all material respects, the financial condition
      and results of operations of the
Company.





The foregoing certification shall not be
deemed to be filed for purposes of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to liability under that
section.  This certification shall not be deemed to be incorporated by
reference into any filing under the Securities Act of 1933 or the Exchange Act
except to the extent this Exhibit 32.1 is expressly and specifically
incorporated by reference in any such filing.








Date: June 27,
      2008
            
            /s/ Allen T.
      SterlingName:  Allen T.
      SterlingTitle:    President
      and
Chief Executive Officer








A signed original of this written
statement required by 18 U.S.C. Section 1350 has been provided to the
Company and will be retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.
[Federal Register Volume 73, Number 5 (Tuesday, January 8, 2008)]
[Notices]
[Page 1325]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-16]


=======================================================================
-----------------------------------------------------------------------

COMMISSION OF FINE ARTS


2008 National Capital Arts and Cultural Affairs Program

    Notice is hereby given that Public Law 99-190, as amended, 
authorizing the National Capital Arts and Cultural Affairs Program, has 
been funded for 2008 in the amount of $8,367,400.00. All requests for 
information and applications for grants should be sent to: 2008 NCACA 
Grant Program, U.S. Commission of Fine Arts, 401 F Street, NW., Suite 
312, Washington, DC 20001-2728, Phone: 202-504-2200.
    Deadline for receipt of grant applications as 1 March 2008.
    This program provides grants for general operating support of 
organizations whose primary purpose is performing, exhibiting, and/or 
presenting the arts. To be eligible for a grant, organizations must be 
located in the District of Columbia, must be non-profit, non-academic 
institutions of demonstrated national repute, and must have annual 
incomes, exclusive of federal funds, in excess of one million dollars 
for each of the past three years, Organizations seeking grants must 
provide a Dun and Bradstreet (D&S) Data Universal Numbering System 
(DUNS) number when applying.

Thomas E. Luebke,
Secretary, U.S. Commission of Fine Arts.
[FR Doc. 08-16 Filed 1-7-08; 8:45 am]
BILLING CODE 6330-01-M
EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form F-3
(Nos. 333-109876, 333-111512 and 333-119750) and on Forms S-3 (Nos. 333-128377, 333-138872 and
333-139662) and on Forms S-8 (Nos. 333-63580, 333-133258 and 333-140041) of World Heart Corporation of our report dated
March 20, 2008 relating to the financial statements which appear in this Amendment No. 1 on Form 10-KSB/A.

/s/
BURR, PILGER & MAYER LLP

San
Francisco, California
July 16, 2008

---



QuickLinks
**Exhibit 32.1**

 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with theQuarterly Report of Waste2Energy Holdings, Inc.  (the “Company”) onForm 10-Q for the period ended June 30, 2010 as filed with the Securitiesand Exchange Commission on the date hereof (the “Report”), I, Peter Bohan,Chief Executive Officer (Principal Executive Officer) of the Company, certify,pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 ofthe Sarbanes-Oxley Act of 2002, that:

 
| (1)   | The Report fully complies  with the requirements of section 13(a) or 15(d) of the  Securities Exchange Act of 1934; and                           |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)   | The information contained  in the Report fairly presents, in all material respects, the financial  condition and results of operations of the Company. |

 

 
| Dated: August 23,  2010   | By:    | /s/ Peter Bohan           |
|-------------------------------------|--------|--------------------------------|
|                                |   | Peter Bohan                    |
|                                |   | Chief Executive Officer        |
|                                |   | (Principal Executive  Officer) |

 

1

----